MDxHealth SA Form 6-K Summary
Business Context and Reporting Period
This Form 6-K is a report of a foreign private issuer filed by MDxHealth SA for the month of September 2026. The filing, dated September 3, 2026, incorporates the Company's 2026 Interim Report as Exhibit 99.1. The registrant confirms the accuracy of preliminary financial results previously disclosed in a press release filed on August 13, 2026.
Key Financial Metrics
The provided filing text serves as a cover document and does not contain specific numerical data. Consequently, values for revenue, profit, cash flow, margins, debt, and liquidity are not present in this excerpt. The filing references the attached 2026 Interim Report (Exhibit 99.1) and a prior press release for detailed financial figures.
Material Changes
The filing text does not provide specific details regarding material changes in financial position or operations compared to prior periods. It only confirms the accuracy of preliminary results released in August 2026.
Guidance, Outlook, and Risks
No specific guidance, outlook, management commentary, or risk factors are detailed in the cover text of this Form 6-K. The document notes that the report is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, limiting its liability scope unless expressly incorporated by reference.
Investor Verification Checklist
- Review the attached 2026 Interim Report (Exhibit 99.1) for actual financial statements and metrics.
- Verify the preliminary financial results referenced in the press release filed on August 13, 2026.
- Confirm the incorporation of this report into Registration Statements on Form F-3 (File Nos. 333-292463 and 333-280606) and Form S-8 (File No. 333-294873).
- Note that the filing is signed by Michael McGarrity, Chief Executive Officer.